Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carbidopa/levodopa/entacapone for early Parkinson's disease
NCT00099268Phase 3Completed
- Sponsor
- Novartis
- Start
- Sep 2004
- Primary completion
- Nov 2008
- Modality
- Small Molecules
- Countries
- 14
01
Overview
A Phase 3 trial of levodopa in Parkinson's disease (PD), sponsored by Novartis. Started Sep 2004; status: completed.
02
Drugs
levodopa
03
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT00099268.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00099268.